These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 9411833

  • 1. [Thrombocyte IIb/IIIa receptor inhibitors--a new direction in antithrombotic therapy].
    Panchenko EP.
    Ter Arkh; 1997; 69(9):66-71. PubMed ID: 9411833
    [No Abstract] [Full Text] [Related]

  • 2. The evolving role of glycoprotein IIb/IIIa inhibitor therapy in contemporary care of acute coronary syndrome patients.
    Tricoci P, Peterson ED.
    J Interv Cardiol; 2006 Oct; 19(5):449-55. PubMed ID: 17020570
    [Abstract] [Full Text] [Related]

  • 3. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG.
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract] [Full Text] [Related]

  • 4. Glycoprotein IIb/IIIa antagonist and fibrinolytic agents: new therapeutic regimen for acute myocardial infarction.
    Patel VB, Moliterno DJ.
    J Invasive Cardiol; 2000 Mar; 12 Suppl B():8B-15B. PubMed ID: 10731294
    [No Abstract] [Full Text] [Related]

  • 5. GPIIb/IIIa inhibitor-induced dethrombosis.
    Furman MI, Frelinger AL, Michelson AD.
    J Thromb Thrombolysis; 2004 Aug; 18(1):11-7. PubMed ID: 15744548
    [Abstract] [Full Text] [Related]

  • 6. GP IIb/IIIa blockade during peripheral artery interventions.
    Tepe G, Wiskirchen J, Pereira P, Claussen CD, Miller S, Duda SH.
    Cardiovasc Intervent Radiol; 2008 Aug; 31(1):8-13. PubMed ID: 17479207
    [Abstract] [Full Text] [Related]

  • 7. Fundamentals of coagulation and glycoprotein IIb/IIIa receptor inhibition.
    Ferguson JJ, Waly HM, Wilson JM.
    Eur Heart J; 1998 Apr; 19 Suppl D():D3-9. PubMed ID: 9597517
    [Abstract] [Full Text] [Related]

  • 8. Thrombolytic therapy: new dimensions 2009.
    Guha S, Mukherjee S, Hema MB.
    Indian Heart J; 2009 Apr; 61(5):415-21. PubMed ID: 20635755
    [No Abstract] [Full Text] [Related]

  • 9. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.
    Pereira H, GUSTO V Investigators.
    Rev Port Cardiol; 2001 Jun; 20(6):687-8. PubMed ID: 11525077
    [No Abstract] [Full Text] [Related]

  • 10. Prospective use of platelet glycoprotein IIb/IIIa receptor blockers in the emergency department setting.
    Gibler WB, Wilcox RG, Bode C, Castaigne AD, Delooz H, Elich D, Fox KA, Kereiakes DJ, Rupprecht H, Topol EJ.
    Eur J Emerg Med; 1998 Dec; 5(4):391-402. PubMed ID: 9919443
    [Abstract] [Full Text] [Related]

  • 11. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S, Mezyński G, Kralisz P, Prokopczuk P, Nowak K, Kochman W, Zuk J, Bachórzewska-Gajewska H, Sawicki Z, Poniatowski B, Korecki J, Musiał WJ.
    Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [Abstract] [Full Text] [Related]

  • 12. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
    Ottani F, Bresciani B, La Vecchia L, Favero L, Fontanelli A, Galvani M.
    Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194
    [Abstract] [Full Text] [Related]

  • 13. Glycoprotein IIb/IIIa receptor antagonists: are we ignoring the evidence.
    Singh S, Gopal AK, Bahl VK.
    Indian Heart J; 2005 May; 57(3):201-9. PubMed ID: 16196176
    [No Abstract] [Full Text] [Related]

  • 14. Facilitation of thrombolysis in acute myocardial infarction.
    Gambhir DS.
    Indian Heart J; 1999 May; 51(5):486-8. PubMed ID: 10721636
    [No Abstract] [Full Text] [Related]

  • 15. New antithrombotic agents.
    Weitz JI, Hirsh J.
    Chest; 1998 Nov; 114(5 Suppl):715S-727S. PubMed ID: 9822073
    [No Abstract] [Full Text] [Related]

  • 16. Role of platelet adhesion and aggregation in antithrombotic therapy.
    Ruggeri ZM.
    West J Med; 1993 Dec; 159(6):702-4. PubMed ID: 8128694
    [No Abstract] [Full Text] [Related]

  • 17. Combination therapy in peripheral vascular disease: the rationale of using both thrombolytic and antiplatelet drugs.
    Shlansky-Goldberg R.
    J Am Coll Surg; 2002 Jan; 194(1 Suppl):S103-13. PubMed ID: 11800349
    [No Abstract] [Full Text] [Related]

  • 18. Combination therapy with reduced-dose fibrinolytic and platelet GP IIb/IIIa receptor inhibitors: SPEEDing into GUSTO V.
    Lincoff AM.
    J Invasive Cardiol; 2001 May; 13 Suppl A():16A-18A. PubMed ID: 11458014
    [No Abstract] [Full Text] [Related]

  • 19. Subacute stent thrombosis successfully treated with thrombolysis and glycoprotein IIb/IIIa inhibition.
    Bowater SE, Doshi SN, Buller NP.
    Heart; 2005 Apr; 91(4):488. PubMed ID: 15772208
    [No Abstract] [Full Text] [Related]

  • 20. Future directions in thrombolysis.
    Willerson JT, Zoldhelyi P.
    Clin Cardiol; 1999 Aug; 22(8 Suppl):IV44-53. PubMed ID: 10492853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.